Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06462937

A Digital Exercise Intervention in Patients With Spondyloarthritis

Led by Diakonhjemmet Hospital · Updated on 2024-09-19

260

Participants Needed

1

Research Sites

317 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This protocol describes a 6-month randomised, controlled exercise trial in patients with axial spondyloarthritis (axSpA) with re-randomization after 3-months. The primary outcome of the trial (disease activity) will be evaluated at 3-months. The exercise programme on trial comprises high intensity interval training (HIIT), muscular strength exercise and aerobic physical activity sessions of specified duration, frequency, and intensity. It also includes brief knowledge videos to empower the patient. The intervention is remotely delivered by the SPARK application with personalised follow-up including monitoring to ensure exercise progression and adherence to exercise intensity. The SPARK application is built on a platform delivered by ABEL Technologies (trademark) and is customised for patients with axSpA.

CONDITIONS

Official Title

A Digital Exercise Intervention in Patients With Spondyloarthritis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of axial spondyloarthritis within the last 2 years by a rheumatologist using ASAS criteria
  • Active disease with ankylosing spondylitis disease activity score (ASDAS) greater than 1.3
  • Adult participants aged 18 years or older
Not Eligible

You will not qualify if you...

  • Active uveitis (eye inflammation)
  • C-reactive protein (CRP) level greater than 30
  • Current or previous use of biologic disease modifying anti-rheumatic drugs (bDMARDs)
  • Pregnancy or planning pregnancy within 6 months of enrollment
  • Absolute or relative contraindications to high intensity interval training according to American College of Sports Medicine guidelines
  • Presence of serious diseases such as cancer
  • Inability to follow the study protocol or remote monitoring requirements

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Diakonhjemmet hospital

Oslo, Norway

Actively Recruiting

Loading map...

Research Team

S

Sella A Provan, Professor

CONTACT

B

Birgitte Nellemann, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here